Form 4: Director Buys InfuSystem Shares

Director Paul Andrew Gendron acquired 5,000 shares of InfuSystem Holdings, Inc. common stock for $8.88 per share.

Summary

• Paul Andrew Gendron, a Director at InfuSystem Holdings, Inc., purchased 5,000 shares of common stock on May 8, 2026.
• The purchase was made at a weighted average price of $8.88 per share.
• Following this transaction, Gendron beneficially owns 70,000 shares of common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing due to a director's stock purchase, indicating personal investment and confidence, but without broader financial performance data.

Positives

• Director's confidence indicated by a direct purchase of company stock.
• The purchase price of $8.88 per share suggests a belief in the current valuation or future growth potential.

Future Outlook

No specific forward-looking statements or guidance are present in this filing.

Industry Context

StockSavvy.ai notes that insider purchases, particularly by directors, can signal confidence in the company's prospects, especially within the healthcare technology sector where InfuSystem operates.

Stakeholder Impact

• Shareholders may view this purchase as a positive signal of management's belief in the company's value.
• Employees may be encouraged by the director's investment, potentially reinforcing morale.

Key Dates

Keywords

Form 4, Insider Trading, InfuSystem Holdings, Director Purchase, Common Stock, Beneficial Ownership